174 related articles for article (PubMed ID: 28322321)
1. The clinical effect of nicorandil on perioperative myocardial protection in patients undergoing elective PCI: A Systematic Review and Meta-Analysis.
Ye Z; Su Q; Li L
Sci Rep; 2017 Mar; 7():45117. PubMed ID: 28322321
[TBL] [Abstract][Full Text] [Related]
2. Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.
Zhu H; Xu X; Fang X; Zheng J; Chen T; Huang J
Medicine (Baltimore); 2019 Jan; 98(3):e14165. PubMed ID: 30653160
[TBL] [Abstract][Full Text] [Related]
3. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
Pang Z; Zhao W; Yao Z
Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention.
Shehata M
J Interv Cardiol; 2014 Oct; 27(5):472-81. PubMed ID: 25174952
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention.
Zhao XT; Zhang CF; Liu QJ
BMC Cardiovasc Disord; 2019 Jun; 19(1):144. PubMed ID: 31200660
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Nicorandil in Preventing Contrast-Induced Nephropathy after Elective Percutaneous Coronary Intervention: A Pooled Analysis of 1229 Patients.
Yi B; Mo S; Jiang Y; Yi D; Luo J; Chen X; Rong J
J Interv Cardiol; 2020; 2020():4527816. PubMed ID: 32982608
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial.
Ye Z; Lu H; Su Q; Long M; Li L
Drug Des Devel Ther; 2018; 12():2591-2599. PubMed ID: 30174413
[TBL] [Abstract][Full Text] [Related]
9. Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial.
Zhang W; Dai J; Zheng X; Xu K; Yang X; Shen L; Wang X; Hao Z; Qiu X; Jiang L; Shi H; Shen L; He B
Medicine (Baltimore); 2021 Apr; 100(15):e25551. PubMed ID: 33847683
[TBL] [Abstract][Full Text] [Related]
10. Nicorandil suppressed myocardial injury after percutaneous coronary intervention.
Isono T; Kamihata H; Sutani Y; Motohiro M; Yamamoto S; Kyoui S; Iharada Y; Kurimoto K; Hara K; Takahashi H; Iwasaka T
Int J Cardiol; 2008 Jan; 123(2):123-8. PubMed ID: 17346816
[TBL] [Abstract][Full Text] [Related]
11. Nicorandil for Periprocedural Myocardial Injury in Elective Percutaneous Coronary Intervention: A Meta-Analysis of 10 Randomized Controlled Trials.
Yi B; Luo J; Jiang Y; Mo S; Xiao X; Chen X; Rong J
Angiology; 2020 Aug; 71(7):609-615. PubMed ID: 32295385
[TBL] [Abstract][Full Text] [Related]
12. Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trial.
Miyoshi T; Ejiri K; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Takaishi A; Kawai Y; Sato T; Sato K; Oka T; Takahashi N; Sakuragi S; Mima A; Enko K; Hosogi S; Nanba S; Hirami R; Nakamura K; Ito H;
Int J Cardiol; 2017 Jun; 236():36-42. PubMed ID: 28214082
[TBL] [Abstract][Full Text] [Related]
13. Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.
Sato S; Takahashi M; Mikamo H; Kawazoe M; Iizuka T; Shimizu K; Noro M; Shirai K
Heart Vessels; 2020 Dec; 35(12):1664-1671. PubMed ID: 32572567
[TBL] [Abstract][Full Text] [Related]
14. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
[TBL] [Abstract][Full Text] [Related]
15. Effect of Nicorandil Administration on Preventing Contrast-Induced Nephropathy: A Meta-Analysis.
Zhan B; Huang X; Jiang L; Bao H; Cheng X
Angiology; 2018 Aug; 69(7):568-573. PubMed ID: 28950711
[TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.
Yang J; Zhang J; Cui W; Liu F; Xie R; Yang X; Gu G; Zheng H; Lu J; Yang X; Zhang G; Wang Q; Geng X
Anatol J Cardiol; 2015 Feb; 15(2):125-31. PubMed ID: 25252296
[TBL] [Abstract][Full Text] [Related]
17. Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial.
An S; Huang H; Wang H; Jiang Y
Medicine (Baltimore); 2021 Apr; 100(15):e25500. PubMed ID: 33847663
[TBL] [Abstract][Full Text] [Related]
18. The effect of nicorandil in patients with acute myocardial infarction undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Ji Z; Zhang R; Lu W; Ma G; Qu Y
Ir J Med Sci; 2020 Feb; 189(1):119-131. PubMed ID: 31147987
[TBL] [Abstract][Full Text] [Related]
19. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Geng N; Ren L; Xu L; Zou D; Pang W
BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
